stockrow
Friday 6 November 2026
Export ASPN’s income statement to Excel — free account
Aspen Aerogels, Inc.
ASPN Basic Materials Specialty Chemicals
Aspen Aerogels, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $271.1 million, down 40.1% from fiscal 2024.
- Revenue
- +16.7%
- EPS
- −62.5%
- Free cash flow
- −93.1%
- Total debt
- −79.6%
Quarter to September 2026, against a year earlier
4.90
0.26
−5.04%
Follow ASPN
Alert me
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 From the 10-Q filed 5 Nov | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
0.86 | 1.23 | 2.60 | 2.12 | |
P/FCF ratio |
0.00 | 7.96 | 15.29 | 15.78 | |
P/Operating CF |
14.44 | 8.29 | (32.44) | (121.30) | |
P/B ratio |
0.99 | 1.33 | 2.73 | 2.47 | |
Price to Tangible BV |
0.99 | 1.33 | 2.73 | 2.47 | |
EV/Sales |
0.68 | 0.87 | 2.30 | 1.87 | |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Operating CF |
5.61 | 3.26 | 9.48 | 13.24 | |
EV/FCF |
(40.26) | 5.62 | 13.55 | 13.91 | |
Quick Ratio |
3.13 | 2.41 | 1.96 | 1.71 | |
Current Ratio |
3.90 | 2.89 | 2.52 | 2.10 | |
Net Debt/EBITDA |
1.18 | 6.05 | 2.62 | 0.00 | |
Debt/Assets |
27.02% | 22.54% | 23.82% | 5.70% | |
Debt/Equity |
0.47 | 0.43 | 0.49 | 0.12 | |
Asset Turnover |
0.42 | 0.48 | 0.44 | 0.48 | |
Operating CF/Net income |
(0.22) | (1.44) | 0.70 | 0.36 | |
Capex/Depreciation |
(0.08) | (0.19) | (0.30) | 0.00 | |
Interest Coverage |
— | (6.61) | (10.37) | — | |
Research and Development Expense of Revenue |
6.76% | 7.19% | 6.41% | 2.91% | |
Selling, General and Administrative Expense of Revenue |
52.46% | 57.96% | 40.01% | 24.18% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
4.06% | 4.93% | 3.75% | 1.93% | |
Graham Net Nets |
0.30 | 0.20 | 0.09 | 0.10 | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
(167.49%) | (39.77%) | (24.13%) | (28.83%) | |
Free Cash Flow Yield |
(1.96%) | 12.57% | 6.54% | 6.34% | |
Revenue per Share |
0.50 | 0.46 | 0.60 | 1.03 | |
Operating CF per Share |
0.20 | 0.41 | (0.20) | (0.05) | |
Capex per Share |
(0.03) | (0.02) | (0.02) | 0.05 | |
Free Cash Flow per Share |
0.17 | 0.40 | (0.22) | 0.00 | |
Cash per Share |
1.93 | 2.12 | 1.85 | 1.76 | |
Shareholders Equity per Share |
2.86 | 2.58 | 2.32 | 2.22 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
2.86 | 2.58 | 2.32 | 2.22 | |
Free Cash Flow |
13.67 | 32.78 | (18.00) | 0.41 | |
Working Capital |
180.03 | 166.17 | 149.85 | 134.67 | |
Capital Expenditures |
(2.46) | (1.37) | (1.80) | 4.16 | |
Net Current Asset Value |
70.89 | 56.99 | 48.02 | 46.90 | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.06 | 0.04 | 0.04 | (0.05) | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
72.19 | 56.90 | 58.22 | 65.70 | |
Average Payables |
28.80 | 26.77 | 23.98 | 28.14 | |
Average Inventory |
42.90 | 43.90 | 40.03 | 36.17 | |
Average Assets |
650.91 | 482.73 | 459.03 | 442.75 | |
Average Common Equity |
425.11 | 264.17 | 250.62 | 245.09 |
Columns are period end dates · fundamentals updated 5 Nov 2026